Labitad, Rhen Heart L.
HRN: 21-93-90 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/05/2024
CLARITHROMYCIN 125MG/5ML, 60ML SUSPENSION (BOT)
04/05/2024
04/11/2024
PO
3ml
BID
PCAP C
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes